Strong Demand from Biopharma Industry Will Hasten NGS Informatics Providers to Boost Customized Solutions
To access more information on this analysis, please click here.
Frost & Sullivan expects the European NGS informatics market to be worth $508.6 million by 2021. Trends supporting market development include:Focus on personalized medicine across European nations such as France, Germany, and the United Kingdom (U.K.) along with a number of pan-Europe initiatives;National-level genomics data collection and analysis initiative such as UK's 100,000 Genomes Project and the French Plan for Genomic Medicine 2025;Strong research and development (R&D) and wider application of NGS informatics-based services in Benelux and the Nordics; andPresence of cutting-edge NGS technology infrastructure in the region, like the Wellcome Trust Sanger Institute, a highly educated population receptive to NGS technologies and significant government support.
"Europe is a fragmented market, where revenue potential varies significantly in individual countries. Additionally, at a pan-European market level, countries have differing regulations and reimbursement practices that may hamper successful commercialization of NGS informatics solutions," observed Goswami. "However, innovative approaches, such as storing genomic data for analysis within specified geographic borders to match data storage regulations, and evolution in reimbursement policies that increase clarity and coverage for NGS-based tests, will support growth opportunities."
As service providers build comprehensive service capabilities, mergers, acquisitions, and collaborations are likely to increase across the NGS value chain. Companies to watch in this space include QIAGEN, Illumina, Congenica, Eagle Genomics, BC Platforms, Bluebee, Sophia Genetics, Genestack, and GENALICE.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021
P: +1 (210) 348 1012